Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Ramírez

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Drugs in Context|February 16, 2023
Lurasidone for the treatment of schizophrenia in adult and paediatric populationsTeresa Guilera, Juan Pablo Chart Pascual, Maria Del Carmen Blasco, et al.
Journal of Alzheimer'S Disease : JAD|November 5, 2016
Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1Mariateresa Buongiorno, Francesca Antonelli, Yaroslau Compta, et al.
The Lancet. Infectious Diseases|April 1, 2022
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority studyDiana Leticia Coronel-Martinez, Juliana Park, Eduardo López-Medina, et al.
The Lancet. Infectious Diseases|November 19, 2020
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority studyDiana Leticia Coronel-MartÍnez, Juliana Park, Eduardo López-Medina, et al.
Human Genetics|April 11, 2020
CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrixJuan-Manuel Bonet-Fernández, José-Daniel Aroca-Aguilar, Marta Corton, et al.
Maturitas|September 9, 2022
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria GroupNicolás Mendoza, Isabel Ramírez, Esther de la Viuda, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Drugs in Context|February 16, 2023
Lurasidone for the treatment of schizophrenia in adult and paediatric populationsTeresa Guilera, Juan Pablo Chart Pascual, Maria Del Carmen Blasco, et al.
Journal of Alzheimer'S Disease : JAD|November 5, 2016
Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1Mariateresa Buongiorno, Francesca Antonelli, Yaroslau Compta, et al.
The Lancet. Infectious Diseases|April 1, 2022
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority studyDiana Leticia Coronel-Martinez, Juliana Park, Eduardo López-Medina, et al.
The Lancet. Infectious Diseases|November 19, 2020
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority studyDiana Leticia Coronel-MartÍnez, Juliana Park, Eduardo López-Medina, et al.
Human Genetics|April 11, 2020
CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrixJuan-Manuel Bonet-Fernández, José-Daniel Aroca-Aguilar, Marta Corton, et al.
Maturitas|September 9, 2022
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria GroupNicolás Mendoza, Isabel Ramírez, Esther de la Viuda, et al.
Pageof 6